Obstructive sleep apnea syndrome is a systemic disease. Current evidence
Authors:
- Carlos ZamarronCZCarlos Zamarron
- Vanesa García PazVPVanesa García Paz
- Alberto RiveiroARAlberto Riveiro
- 1 October 2008
- journal article
- review article
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 19 (6) , 390-398
Abstract
No abstract availableKeywords
This publication has 139 references indexed in Scilit:
- Treatment of obstructive sleep apnoea leads to improved microvascular endothelial function in the systemic circulationThorax, 2006
- Oxidative stress and oxidant signaling in obstructive sleep apnea and associated cardiovascular diseasesFree Radical Biology and Medicine, 2006
- Leptin and Ghrelin Levels in Patients with Obstructive Sleep Apnea SyndromeRespiration, 2005
- Inflammation, Atherosclerosis, and Coronary Artery DiseaseNew England Journal of Medicine, 2005
- Adiponectin in Patients with Obstructive Sleep Apnea Syndrome: Course and Physiological RelevanceRespiration, 2004
- C-Reactive Protein, the Metabolic Syndrome, and Prediction of Cardiovascular Events in the Framingham Offspring StudyCirculation, 2004
- Should C-Reactive Protein Be Added to Metabolic Syndrome and to Assessment of Global Cardiovascular Risk?Circulation, 2004
- Obesity, Sleep Apnea, and HypertensionHypertension, 2003
- Intermittent Hypoxia Increases Insulin Resistance in Genetically Obese MiceThe Journal of Physiology, 2003
- Plasma leptin levels and cardiac sympathetic function in patients with obstructive sleep apnoea-hypopnoea syndromeThorax, 2002